2023
DOI: 10.2147/dddt.s427530
|View full text |Cite
|
Sign up to set email alerts
|

Oral Isotretinoin and Its Uses in Dermatology: A Review

Anon Paichitrojjana,
Anand Paichitrojjana

Abstract: In 1982, the Food and Drug Administration (FDA) of the United States of America approved isotretinoin (13-cis-retinoic acid), a retinoid derivative of vitamin A, to treat severe recalcitrant acne vulgaris. Apart from its prescribed use for severe acne, evidence suggests that isotretinoin is commonly used off-label to treat mild-to-moderate acne, inflammatory skin conditions, genodermatoses, skin cancer, and other skin disorders. This is due to its anti-inflammatory, immunomodulatory, and antineoplastic propert… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0
4

Year Published

2024
2024
2025
2025

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 152 publications
0
5
0
4
Order By: Relevance
“…Isotretinoin is known for its diverse effects on severe acne and is also involved in decreasing the presence of P. acnes via changing the skin's microenvironment. However, the complete efficacy of isotretinoin is sometimes restricted by its inadequate solubility and bioavailability ( Paichitrojjana and Paichitrojjana, 2023 ). Improving these pharmacokinetic features using a self-nanoemulsifying drug delivery system (SNEDDS) could potentially enhance the inhibitory effect on P. acnes , resulting in a more effective acne treatment regimen ( Hosny et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…Isotretinoin is known for its diverse effects on severe acne and is also involved in decreasing the presence of P. acnes via changing the skin's microenvironment. However, the complete efficacy of isotretinoin is sometimes restricted by its inadequate solubility and bioavailability ( Paichitrojjana and Paichitrojjana, 2023 ). Improving these pharmacokinetic features using a self-nanoemulsifying drug delivery system (SNEDDS) could potentially enhance the inhibitory effect on P. acnes , resulting in a more effective acne treatment regimen ( Hosny et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…Системные ретиноиды обладают противовоспалительным, антифибротическим, антиангиогенным и антиоксидантным действием. Изотретиноин снижает экспрессию патоген-ассоциированных Toll-подобных рецепторов 2-го типа, что способствует подавлению воспаления и уменьшает приток крови к лицу [10,[16][17][18]. Он способствует уменьшению размеров сальных желез, регулирует пролиферацию себоцитов, подавляет выработку кожного сала, изменяет микробиом кожи и снижает число Demodex spp.…”
Section: системная терапияunclassified
“…Он способствует уменьшению размеров сальных желез, регулирует пролиферацию себоцитов, подавляет выработку кожного сала, изменяет микробиом кожи и снижает число Demodex spp. [17].…”
Section: системная терапияunclassified
See 1 more Smart Citation
“…Характерно, що виникає клітинноопосередкована запальна відповідь, в якій переважають макрофаги та Т-хелпери (Th)-1 і Th-17 [13,14].…”
unclassified